P2 purinergic receptor modulation of cytokine production.
about
Smoking enhances the proinflammatory effects of nucleotides on cytokine release from human lung.Extracellular ATP and P2Y receptor activation induce a proinflammatory host response in the human urinary tract.Biochemical regulation of sleep and sleep biomarkersThe therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.Gene expression profiling in dermatitis herpetiformis skin lesions.Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activationExtracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.Expression, signaling, and function of P2X7 receptors in bone.The role of cytokines in sleep regulationEmerging role of extracellular nucleotides and adenosine in multiple sclerosis.Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain.The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.IL-8 and global gene expression analysis define a key role of ATP in renal epithelial cell responses induced by uropathogenic bacteria.P2 receptor-mediated signaling in mast cell biologyAdenosine triphosphate induces P2Y2 activation and interleukin-8 release in human esophageal epithelial cells.Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes.The P2X7 receptor: a key player in immune-mediated bone loss?
P2860
Q33825440-95D7951B-9C83-417C-8227-8A5D70A667B0Q34045172-45F19C16-6F4E-4282-8AAF-623E4DE84451Q35306427-7BD6680F-8ADB-47DB-90D4-331308101F13Q35932071-BE8A9094-7C47-4DB8-B1B9-F00E4B796C3DQ36237602-08B8F97B-A07B-4F7F-8D66-5A6070538FF1Q36454202-98CE966D-6389-42FD-9186-BB0E7C433097Q36568428-DBF030DD-40B1-4333-A227-CA48EBA884C3Q36796093-1D6C29AF-E4D1-43A1-B6C9-10323ED998F5Q37203211-91CD9213-90B6-41BF-B6AA-F78E4BAB0CBAQ37347398-35729A38-6EBA-4C75-950E-6B816AE65F2CQ37906358-3683A6CD-BA9C-4827-8890-5EDE7D46B3A0Q38135247-BDD7798E-458A-4EC6-86F9-85FF12A01116Q38704818-BFBF6690-1E2D-4AFD-8E30-9E14C3005131Q38996053-3BB621BD-42A6-40A2-8CD6-3166655B8BD9Q39600738-29906712-0DFD-4DE4-A474-BC0E4BC3AEC3Q51261542-46AE9A8E-FB54-4FA8-A8BC-A35FC76CA199Q54526365-C8EC4B32-8036-4B4A-ACEB-435D410E983FQ55717414-6EA84C4C-F701-4FE9-8955-FFF964861E54
P2860
P2 purinergic receptor modulation of cytokine production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
P2 purinergic receptor modulation of cytokine production.
@en
P2 purinergic receptor modulation of cytokine production.
@nl
type
label
P2 purinergic receptor modulation of cytokine production.
@en
P2 purinergic receptor modulation of cytokine production.
@nl
prefLabel
P2 purinergic receptor modulation of cytokine production.
@en
P2 purinergic receptor modulation of cytokine production.
@nl
P2860
P1476
P2 purinergic receptor modulation of cytokine production.
@en
P2093
Christopher A Gabel
P2860
P2888
P356
10.1007/S11302-006-9034-Y
P577
2007-01-03T00:00:00Z